• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: autologous logic-gated Tmod chimeric antigen receptor (CAR) T cells expressing a carcinoembryonic antigen targeted CAR activator and a human leukocyte antigen serotype A*02 (HLA-A*02) targeted blocker
Date Designated: 02/22/2024
Orphan Designation: Treatment of germline heterozygous HLA-A*02(+) patients with colorectal cancer that expresses CEA and has lost HLA A*02 expression
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
A2 Biotherapeutics, Inc.
30301 Agoura Road, Suite 210
Agoura Hills, California 91301
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-